This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perera, L P Articles by Hay, J Search for Related Content PubMed PubMed Citation Articles by Perera, L P Articles by Hay, J

Regulation of varicella-zoster virus gene expression in human T lymphocytes.

Department of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.

ABSTRACT

Varicella-zoster virus (VZV), a neurotropic alphaherpesvirus, is the etiologic agent of chicken pox and shingles (zoster) in humans. Using an in vitro transient expression assay, we have evaluated the ability of the putative immediate early VZV genes, ORF4, ORF61, and ORF62 (the analogs of the herpes simplex virus alpha 27, alpha 0, and alpha 4 genes, respectively), to modulate the expression of VZV genes of different putative kinetic classes in a human T lymphocyte cell line. These cells are of the type in which VZV can be readily detected in the viremic phase of human infection. We present evidence to indicate that, in this system, the gene product of ORF62 (IE62) is a major regulatory protein in VZV and is capable of activating VZV genes of all putative kinetic classes. In addition, we demonstrate that the gene product of ORF4 and, unlike the apparent situation in Vero cells, the gene product of ORF61 may play an accessory regulatory role in synergizing the activation of VZV genes induced by the gene product of ORF62 in human T lymphocytes.

This article has been cited by other articles:

• Tischer, B. K., Kaufer, B. B., Sommer, M., Wussow, F., Arvin, A. M., Osterrieder, N. (2007). A Self-Excisable Infectious Bacterial Artificial Chromosome Clone of Varicella-Zoster Virus Allows Analysis of the Essential Tegument Protein Encoded by ORF9. J. Virol. 81: 13200-13208 [Abstract] [Full Text]  
• Berarducci, B., Sommer, M., Zerboni, L., Rajamani, J., Arvin, A. M. (2007). Cellular and Viral Factors Regulate the Varicella-Zoster Virus gE Promoter during Viral Replication. J. Virol. 81: 10258-10267 [Abstract] [Full Text]  
• Yang, M., Peng, H., Hay, J., Ruyechan, W. T. (2006). Promoter Activation by the Varicella-Zoster Virus Major Transactivator IE62 and the Cellular Transcription Factor USF.. J. Virol. 80: 7339-7353 [Abstract] [Full Text]  
• Gary, L., Gilden, D. H., Cohrs, R. J. (2006). Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal Ganglia.. J. Virol. 80: 4921-4926 [Abstract] [Full Text]  
• Che, X., Zerboni, L., Sommer, M. H., Arvin, A. M. (2006). Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.. J. Virol. 80: 3238-3248 [Abstract] [Full Text]  
• Hoover, S. E., Cohrs, R. J., Rangel, Z. G., Gilden, D. H., Munson, P., Cohen, J. I. (2006). Downregulation of Varicella-Zoster Virus (VZV) Immediate-Early ORF62 Transcription by VZV ORF63 Correlates with Virus Replication In Vitro and with Latency.. J. Virol. 80: 3459-3468 [Abstract] [Full Text]  
• Habran, L., Bontems, S., Di Valentin, E., Sadzot-Delvaux, C., Piette, J. (2005). Varicella-Zoster Virus IE63 Protein Phosphorylation by Roscovitine-sensitive Cyclin-dependent Kinases Modulates Its Cellular Localization and Activity. J. Biol. Chem. 280: 29135-29143 [Abstract] [Full Text]  
• Cohen, J. I., Krogmann, T., Ross, J. P., Pesnicak, L., Prikhod'ko, E. A. (2005). Varicella-Zoster Virus ORF4 Latency-Associated Protein Is Important for Establishment of Latency. J. Virol. 79: 6969-6975 [Abstract] [Full Text]  
• Ku, C.-C., Besser, J., Abendroth, A., Grose, C., Arvin, A. M. (2005). Varicella-Zoster Virus Pathogenesis and Immunobiology: New Concepts Emerging from Investigations with the SCIDhu Mouse Model. J. Virol. 79: 2651-2658 [Full Text]  
• Peng, H., He, H., Hay, J., Ruyechan, W. T. (2003). Interaction between the Varicella Zoster Virus IE62 Major Transactivator and Cellular Transcription Factor Sp1. J. Biol. Chem. 278: 38068-38075 [Abstract] [Full Text]  
• Sato, B., Ito, H., Hinchliffe, S., Sommer, M. H., Zerboni, L., Arvin, A. M. (2003). Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo. J. Virol. 77: 5607-5620 [Abstract] [Full Text]  
• Besser, J., Sommer, M. H., Zerboni, L., Bagowski, C. P., Ito, H., Moffat, J., Ku, C.-C., Arvin, A. M. (2003). Differentiation of Varicella-Zoster Virus ORF47 Protein Kinase and IE62 Protein Binding Domains and Their Contributions to Replication in Human Skin Xenografts in the SCID-hu Mouse. J. Virol. 77: 5964-5974 [Abstract] [Full Text]  
• Ito, H., Sommer, M. H., Zerboni, L., He, H., Boucaud, D., Hay, J., Ruyechan, W., Arvin, A. M. (2002). Promoter Sequences of Varicella-Zoster Virus Glycoprotein I Targeted by Cellular Transactivating Factors Sp1 and USF Determine Virulence in Skin and T Cells in SCIDhu Mice In Vivo. J. Virol. 77: 489-498 [Abstract] [Full Text]  
• Ku, C.-C., Padilla, J. A., Grose, C., Butcher, E. C., Arvin, A. M. (2002). Tropism of Varicella-Zoster Virus for Human Tonsillar CD4+ T Lymphocytes That Express Activation, Memory, and Skin Homing Markers. J. Virol. 76: 11425-11433 [Abstract] [Full Text]  
• Gomi, Y., Sunamachi, H., Mori, Y., Nagaike, K., Takahashi, M., Yamanishi, K. (2002). Comparison of the Complete DNA Sequences of the Oka Varicella Vaccine and Its Parental Virus. J. Virol. 76: 11447-11459 [Abstract] [Full Text]  
• Sato, H., Callanan, L. D., Pesnicak, L., Krogmann, T., Cohen, J. I. (2002). Varicella-Zoster Virus (VZV) ORF17 Protein Induces RNA Cleavage and Is Critical for Replication of VZV at 37oC but Not 33oC. J. Virol. 76: 11012-11023 [Abstract] [Full Text]  
• Bontems, S., Di Valentin, E., Baudoux, L., Rentier, B., Sadzot-Delvaux, C., Piette, J. (2002). Phosphorylation of Varicella-Zoster Virus IE63 Protein by Casein Kinases Influences Its Cellular Localization and Gene Regulation Activity. J. Biol. Chem. 277: 21050-21060 [Abstract] [Full Text]  
• Kinchington, P. R., Fite, K., Seman, A., Turse, S. E. (2001). Virion Association of IE62, the Varicella-Zoster Virus (VZV) Major Transcriptional Regulatory Protein, Requires Expression of the VZV Open Reading Frame 66 Protein Kinase. J. Virol. 75: 9106-9113 [Abstract] [Full Text]  
• Kenyon, T. K., Lynch, J., Hay, J., Ruyechan, W., Grose, C. (2001). Varicella-Zoster Virus ORF47 Protein Serine Kinase: Characterization of a Cloned, Biologically Active Phosphotransferase and Two Viral Substrates, ORF62 and ORF63. J. Virol. 75: 8854-8858 [Abstract] [Full Text]  
• Kinchington, P. R., Fite, K., Turse, S. E. (2000). Nuclear Accumulation of IE62, the Varicella-Zoster Virus (VZV) Major Transcriptional Regulatory Protein, Is Inhibited by Phosphorylation Mediated by the VZV Open Reading Frame 66 Protein Kinase. J. Virol. 74: 2265-2277 [Abstract] [Full Text]  
• Perera, L. P. (2000). The TATA Motif Specifies the Differential Activation of Minimal Promoters by Varicella Zoster Virus Immediate-early Regulatory Protein IE62. J. Biol. Chem. 275: 487-496 [Abstract] [Full Text]  
• de Maisieres, P. D.-T., Baudoux-Tebache, L., Merville, M.-P., Rentier, B., Bours, V., Piette, J. (1998). Activation of the Human Immunodeficiency Virus Long Terminal Repeat by Varicella-zoster Virus IE4 Protein Requires Nuclear Factor-kappa B and Involves Both the Amino-terminal and the Carboxyl-terminal Cysteine-rich Region. J. Biol. Chem. 273: 13636-13644 [Abstract] [Full Text]  
• Cohrs, R. J., Barbour, M., Gilden, D. H. (1998). Varicella-Zoster Virus Gene 21: Transcriptional Start Site and Promoter Region. J. Virol. 72: 42-47 [Abstract] [Full Text]  
• Baudoux, L., Defechereux, P., Rentier, B., Piette, J. (2000). Gene Activation by Varicella-Zoster Virus IE4 Protein Requires Its Dimerization and Involves Both the Arginine-rich Sequence, the Central Part, and the Carboxyl-terminal Cysteine-rich Region. J. Biol. Chem. 275: 32822-32831 [Abstract] [Full Text]